Technical Analysis for AZRX - AzurRx BioPharma, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| See historical AZRX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Wide Bands | Range Expansion | -1.24% | |
| Up 3 Days in a Row | Strength | -1.24% | |
| Upper Bollinger Band Touch | Strength | -1.24% | |
| 50 DMA Support | Bullish | -0.09% | |
| MACD Bullish Centerline Cross | Bullish | -0.09% | |
| Doji - Bearish? | Reversal | -0.09% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Azurrx Biopharma, Inc. is a biopharmaceutical company. It focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. The company's product pipeline consists of MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency and AZX1101, a recombinant enzyme for the prevention of hospital-acquired C.difficile infections. Azurrx Biopharma, Inc. is headquartered in New York City.
Biotechnology Biopharmaceutical Life Sciences Biology Molecular Biology Insulin Gastrointestinal Diseases Synthetic Biology Exocrine Pancreatic Insufficiency Recombinant Dna Treatment Of Gastrointestinal Diseases
Biotechnology Biopharmaceutical Life Sciences Biology Molecular Biology Insulin Gastrointestinal Diseases Synthetic Biology Exocrine Pancreatic Insufficiency Recombinant Dna Treatment Of Gastrointestinal Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AZRX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 3.1 |
| 52 Week Low | 0.416 |
| Average Volume | 384,433 |
| 200-Day Moving Average | 1.5506 |
| 50-Day Moving Average | 0.7378 |
| 20-Day Moving Average | 0.7047 |
| 10-Day Moving Average | 0.7162 |
| Average True Range | 0.0934 |
| ADX | 19.0 |
| +DI | 28.2828 |
| -DI | 14.6694 |
| Chandelier Exit (Long, 3 ATRs ) | 0.6098 |
| Chandelier Exit (Short, 3 ATRs ) | 0.8803 |
| Upper Bollinger Band | 0.8214 |
| Lower Bollinger Band | 0.588 |
| Percent B (%b) | 0.87 |
| BandWidth | 33.120477 |
| MACD Line | 0.0127 |
| MACD Signal Line | -0.0037 |
| MACD Histogram | 0.0164 |
| Fundamentals | Value |
|---|---|
| Market Cap | 8.87 Million |
| Num Shares | 11.2 Million |
| EPS | -1.64 |
| Price-to-Earnings (P/E) Ratio | -0.48 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 7.63 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.90 | ||||
| Resistance 3 (R3) | 0.91 | 0.88 | 0.88 | ||
| Resistance 2 (R2) | 0.88 | 0.86 | 0.88 | 0.87 | |
| Resistance 1 (R1) | 0.84 | 0.84 | 0.83 | 0.83 | 0.87 |
| Pivot Point | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 |
| Support 1 (S1) | 0.77 | 0.79 | 0.76 | 0.76 | 0.71 |
| Support 2 (S2) | 0.74 | 0.77 | 0.74 | 0.71 | |
| Support 3 (S3) | 0.70 | 0.74 | 0.70 | ||
| Support 4 (S4) | 0.69 |
